BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1467524)

  • 1. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
    Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
    Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
    Kita K; Nakase K; Miwa H; Masuya M; Nishii K; Morita N; Takakura N; Otsuji A; Shirakawa S; Ueda T
    Blood; 1992 Jul; 80(2):470-7. PubMed ID: 1378322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunophenotypic analysis of acute myeloid leukemia with t(8;21)].
    Fan L; Wu YJ; Zhang JF; Qiu HR; Qiao C; Wang R; Yang H; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1410-3. PubMed ID: 21176340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
    Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
    Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
    Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
    Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
    Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are some cases of acute leukemia with t(8;21) hybrid leukemias?
    Sun GX; Sparkes RS; Wormsley S; Naeim F; Champlin R; Gale RP
    Cancer Genet Cytogenet; 1990 Oct; 49(2):177-84. PubMed ID: 2170002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-).
    García Vela JA; Martin M; Delgado I; García Alonso L; Monteserin MC; Benito L; Somolinos N; Oña F
    Ann Hematol; 1999 May; 78(5):237-40. PubMed ID: 10391105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
    Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
    Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
    Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic, cytogenetic and clinical features of 192 AML patients in China.
    Tong H; Lu C; Zhang J; Liu Z; Ma Y
    Clin Exp Med; 2009 Jun; 9(2):149-55. PubMed ID: 19205620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
    Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
    Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of aberrant phenotypes in acute myeloblastic leukemia.
    Macedo A; Orfão A; Vidriales MB; López-Berges MC; Valverde B; González M; Caballero MD; Ramos F; Martínez M; Fernández-Calvo J
    Ann Hematol; 1995 Apr; 70(4):189-94. PubMed ID: 7748963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.